Coya Therapeutics
(NASDAQ) COYA
Coya Therapeutics Financials at a Glance
Market Cap
$94.06M
Revenue (TTM)
$7.95M
Net Income (TTM)
$21.23M
EPS (TTM)
$-1.20
P/E Ratio
-3.34
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.01
Volume
1,377
Open
$4.05
Price
$4.01
Volume
1,377
Open
$4.05
Previous Close
$4.01
Daily Range
$3.91 - $4.05
52-Week Range
$3.71 - $7.75
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$4.01
Volume
1,377
Open
$4.05
Previous Close
$4.01
Daily Range
$3.91 - $4.05
52-Week Range
$3.71 - $7.75
COYA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Coya Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Arun Swaminathan, PhD
Website
www.coyatherapeutics.comHeadquarters
Houston, TX 77057, US
COYA Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-51%
Return on Capital
-46%
Return on Assets
-42%
Earnings Yield
-29.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$94.06M
Shares Outstanding
23.46M
Volume
1.38K
Short Interest
0.00%
Avg. Volume
194.96K
Financials (TTM)
Gross Profit
$7.92M
Operating Income
$20.27M
EBITDA
$20.24M
Operating Cash Flow
$10.74M
Capital Expenditure
$0.00
Free Cash Flow
$10.74M
Cash & ST Invst.
$46.82M
Total Debt
$0.00
Coya Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.96M
+202768.8%
Gross Profit
$9.16M
+573.3%
Gross Margin
2.31%
N/A
Market Cap
$94.06M
N/A
Market Cap/Employee
$11.76M
N/A
Employees
8
N/A
Net Income
$5.71M
-95.8%
EBITDA
$4.37M
-7.3%
Quarterly Fundamentals
Net Cash
$46.82M
+22.1%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-42.49%
N/A
Return on Invested Capital
-45.98%
N/A
Free Cash Flow
$11.42B
-473780.8%
Operating Cash Flow
$11.42B
-473780.8%